Liudmila Zhaunova on a global Flo app study linking higher physical activity to lower perimenopause symptom burden.
|Videos|November 15, 2022
A new possible solution to vaginal odor?
Author(s)Morgan Ebert
Alyssa Dweck, MD, discusses some recent positive data presented at the 2022 NAMS meeting regarding Clairvee (Bonafide Health) as a potential treatment for vaginal odor.
Advertisement
Alyssa Dweck, MD, gynecologist and chief medical officer of Bonafide Health, discusses some recent positive data presented at the 2022 NAMS meeting regarding Clairvee (Bonafide Health) as a potential treatment for vaginal odor.
Advertisement
Related to this article
Risa Kagan, MD, on bone health prevention in primary care and why baseline bone density testing should come before age 65.
Risa Kagan, MD, on why the menopause transition is a critical window for bone loss and how women can preserve bone mass.
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
A recap of the top video interviews from Contemporary OB/GYN's coverage of The Menopause Society 2026 Annual Meeting in San Diego.
Chrisandra Shufelt, MD, on using a cardiovascular risk score to guide hormone therapy candidacy at menopause.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
What biomarker-guided preeclampsia care could look like
2
Testosterone for women: Global consensus and physiologic dosing
3
Testosterone physiology in women and the long road to approval
4
Testosterone in women: Androgenic adverse events and lab monitoring
5